Simple frailty quiz may help predict chemo risks for seniors with stomach or bowel cancer

NCT ID NCT07184047

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether two simple frailty questionnaires (G8 and VES-13) can predict serious side effects from chemotherapy in people 65 and older with gastrointestinal cancers. Researchers followed 72 patients receiving standard chemotherapy and checked their frailty, nutrition, and muscle health over time. The goal is to help doctors tailor treatment to reduce harm in older, more vulnerable patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors identify which older patients are more likely to have severe side effects from chemotherapy, allowing for more personalized treatment plans.
What could go wrong
This is a small, single-center observational study, not a treatment trial. The results may not apply to all patients or settings, and the frailty scales may not be accurate enough to change practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Etlik City Hospital, Medical Oncology Department

    Ankara, Yenimahalle, 06210, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.